Author/Creator: Shrestha, Sulena - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Shrestha, Sulena

1. Duration of treatment among patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive non-small-cell lung cancer in the USA. (19th March 2019)

Authors:: Lim, Jonathan; Samuelsen, Carl; Golembesky, Amanda; Shrestha, Sulena; Wang, Li; Griebsch, Ingolf
Journal:: Future oncology
Issue:: Volume 15:Number 13(2019)
Page Start:: 1493
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Effect of Renal Function on Dosing of Non–Vitamin K Antagonist Direct Oral Anticoagulants Among Patients With Nonvalvular Atrial Fibrillation. Issue 2 (February 2018)

Authors:: Shrestha, Sulena; Baser, Onur; Kwong, Winghan Jacqueline
Journal:: Annals of pharmacotherapy
Issue:: Volume 52:Issue 2(2018)
Page Start:: 147
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Healthcare resource utilization and costs associated with patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive NSCLC in the United States. (2nd January 2020)

Authors:: Samuelsen, Carl; Lim, Jonathan; Golembesky, Amanda; Shrestha, Sulena; Wang, Li; Griebsch, Ingolf
Journal:: Journal of medical economics
Issue:: Volume 23:Number 1(2020)
Page Start:: 48
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗